Echosens FibroScan Mini

Customer Review 0
Rated 5 out of 5

The Echosens FibroScan Mini is a compact, portable, non-invasive liver assessment system designed to evaluate liver fibrosis and steatosis with exceptional accuracy. Powered by patented VCTE (Vibration-Controlled Transient Elastography) and CAP (Controlled Attenuation Parameter) technologies, it provides fast, reliable liver stiffness measurements for hospitals, clinics, and mobile healthcare programmes.

Share it :

Echosens FibroScan Mini

The Echosens FibroScan Mini is an innovative portable liver fibrosis scanner designed to deliver fast, accurate, and non-invasive liver evaluation. Developed for hospitals, gastroenterology clinics, hepatology departments, and outreach healthcare services, the system provides reliable liver stiffness measurement and steatosis assessment without the need for invasive liver biopsy.

Its lightweight, mobile design allows clinicians to perform liver examinations in multiple clinical environments, making it an ideal solution for facilities that require flexible diagnostic capabilities and multi-site patient care.

Accurate Liver Fibrosis Measurement

The FibroScan Mini uses patented Vibration-Controlled Transient Elastography (VCTE) technology to measure liver stiffness quickly and painlessly. This proven method enables healthcare professionals to assess liver fibrosis in patients with chronic liver disease while reducing the need for invasive diagnostic procedures.

The examination is completed within minutes, providing immediate quantitative results that support clinical decision-making and long-term patient management.

CAP Technology for Liver Fat Assessment

In addition to fibrosis evaluation, the system incorporates Controlled Attenuation Parameter (CAP) technology, allowing clinicians to measure liver fat accumulation during the same examination.

This dual-assessment capability helps identify hepatic steatosis commonly associated with non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD), viral hepatitis, obesity, and diabetes.

By combining fibrosis and fat assessment into one simple examination, the Echosens FibroScan Mini improves diagnostic efficiency and patient comfort.

Portable Design for Flexible Healthcare

The FibroScan 430 MINI+ is engineered for mobility, enabling hospitals and healthcare providers to perform liver assessments across multiple departments, satellite clinics, and community healthcare programmes.

Its compact footprint makes transportation simple while maintaining the high diagnostic performance expected from Echosens liver imaging systems.

This flexibility supports liver screening initiatives, mobile diagnostic services, and routine follow-up examinations for patients requiring regular monitoring.

Reliable Performance and Easy Operation

Designed with clinicians in mind, the FibroScan Mini offers an intuitive interface that simplifies workflow and minimises operator training. The system delivers highly reproducible results with excellent accuracy, allowing healthcare professionals to perform consistent liver assessments efficiently.

Backed by thousands of peer-reviewed clinical publications, its validated technologies have become a trusted standard for non-invasive liver evaluation worldwide.

Clinical Applications

The Echosens FibroScan Mini is suitable for:

  • Liver fibrosis assessment
  • Liver stiffness measurement
  • Fatty liver disease evaluation
  • Hepatitis monitoring
  • Cirrhosis assessment
  • NAFLD and MASLD evaluation
  • Gastroenterology clinics
  • Hepatology departments
  • Community liver screening programs
  • Long-term liver disease monitoring

Why Choose the Echosens FibroScan Mini?

The FibroScan Mini combines portability, clinical accuracy, and advanced non-invasive liver assessment into one compact system. With proven VCTE and CAP technologies, it enables healthcare professionals to evaluate liver fibrosis and steatosis quickly, comfortably, and confidently while improving workflow and reducing dependence on invasive liver biopsy.

Portable design for mobile liver assessment

Patented VCTE  technology for liver stiffness measurement

CAP technology for liver fat quantification

Fast, non-invasive liver fibrosis assessment

Reliable evaluation of liver steatosis

Immediate quantitative diagnostic results

Highly reproducible clinical measurements

Easy-to-use interface for efficient workflow

Ideal for hospitals, clinics, and outreach programs

Validated by extensive international clinical research

Product Specifications

Specification Details
Brand Echosens
Model FibroScan 430 MINI+
Product Type Liver Fibrosis Assessment System
Technology VCTE  & CAP
Examination Non-invasive
Application Liver Fibrosis & Steatosis Assessment
Portability Compact & Mobile
Clinical Use Hepatology, Gastroenterology, Internal Medicine

• Portable, non-invasive liver assessment system designed for remote care and multi-center use
• Mobile and convenient solution for liver disease evaluation
• Patented VCTE technology for precise and clinically validated liver fibrosis measurement
• Liver stiffness results supported by extensive international clinical research
• CAP technology for accurate quantification of liver fat (steatosis)
• Scientifically validated assessment of hepatic steatosis
• Reliable diagnosis of liver fibrosis and cirrhosis for gastroenterology practice
• High accuracy and strong reproducibility across repeated measurements
• Fast, consistent, and dependable test results
• Suitable for use on both male and female patients without limitations
• Hospital-grade performance with durable and user-friendly operation
• Brand-new unit with complete manufacturer support